Intermittent hypoxic pretreatment exacerbates house dust mite‐induced asthma airway inflammation
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.1253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Hao Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Medi…. Hauptthemen laut MEDLINE: Asthma, Respiratory Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Background
Asthma is widely recognized as an inflammatory disorder. In the context of this inflammatory microenvironment, the involvement of hypoxia and its impact on related pathways have drawn considerable attention. However, the exact role of hypoxia, a prevalent environmental factor, in the development and progression of asthma remains poorly understood.
Methods
Mice were treated with house dust mite (HDM) extracts for 23 days to induce asthma. Mice were divided into room air (RA) group and intermittent hypoxic (IH) group by exposing to different conditions and IH preconditioning (IHP) were underwent to the above groups before the hypoxic regimen. Airway inflammation in mice was evaluated by airway hyperresponsiveness, excessive mucus secretion, and recruitment of inflammatory cells. Immunohistochemistry was employed to quantify the expression levels of NF‐κB. Subsequently, the dose of allergen was modified to investigate whether the impact of hypoxia on asthma is affected by different doses of allergens.
Result
Compared to the RA and IH groups, HDM‐treated mice in the IHP group exhibited aggravated inflammatory cell infiltration and airway hyperresponsiveness ( p <.05). Moreover, there was an increased release of inflammatory mediators and higher expression levels of NF‐κB ( p <.05). Importantly, the impact ia on asthma was found to be influenced by high dose of allergen ( p <.05).
Conclusion
IHP treatment potentially exacerbates HDM‐induced airway inflammation in asthma, with the involvement of NF‐κB, particularly under high‐dose allergen stimulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, China.
- Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- Department of Respiratory and Critical Care Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, China.
- Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Provincial Clinical Research Center for Diabetes and Metabolic Disorders, Wuhan, China.
ORCID-Profile: Guogang Xu
Förderung
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Meng, H., Zhang, D., Que, Y., Hu, P., Wang, R., Liao, Y., & Xu, G. (2024). Intermittent hypoxic pretreatment exacerbates house dust mite‐induced asthma airway inflammation. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1253
Vancouver
Meng H, Zhang D, Que Y, Hu P, Wang R, Liao Y, et al. Intermittent hypoxic pretreatment exacerbates house dust mite‐induced asthma airway inflammation. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1253
BibTeX
@article{Meng2024,
author = {Meng, Hao and Zhang, Dongxue and Que, Yifan and Hu, Peng and Wang, Runsheng and Liao, Yunfei and Xu, Guogang},
title = {Intermittent hypoxic pretreatment exacerbates house dust mite‐induced asthma airway inflammation},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.1253}
}
EUVIMED